231 related articles for article (PubMed ID: 20215464)
1. Molecular basis of cyclooxygenase enzymes (COXs) selective inhibition.
Limongelli V; Bonomi M; Marinelli L; Gervasio FL; Cavalli A; Novellino E; Parrinello M
Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5411-6. PubMed ID: 20215464
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of the dynamic mechanism of ligand binding to cyclooxygenase.
Llorens O; Perez JJ; Palomer A; Mauleon D
Bioorg Med Chem Lett; 1999 Oct; 9(19):2779-84. PubMed ID: 10522690
[TBL] [Abstract][Full Text] [Related]
3. The structure of mammalian cyclooxygenases.
Garavito RM; Mulichak AM
Annu Rev Biophys Biomol Struct; 2003; 32():183-206. PubMed ID: 12574066
[TBL] [Abstract][Full Text] [Related]
4. Theoretical studies on the inhibition mechanism of cyclooxygenase-2. Is there a unique recognition site?
Soliva R; Almansa C; Kalko SG; Luque FJ; Orozco M
J Med Chem; 2003 Apr; 46(8):1372-82. PubMed ID: 12672237
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents.
Kurumbail RG; Stevens AM; Gierse JK; McDonald JJ; Stegeman RA; Pak JY; Gildehaus D; Miyashiro JM; Penning TD; Seibert K; Isakson PC; Stallings WC
Nature; 1996 Dec 19-26; 384(6610):644-8. PubMed ID: 8967954
[TBL] [Abstract][Full Text] [Related]
6. COX-2 selectivity and inflammatory processes.
van Ryn J; Trummlitz G; Pairet M
Curr Med Chem; 2000 Nov; 7(11):1145-61. PubMed ID: 11032964
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic insights into cyclooxygenase irreversible inactivation by aspirin.
Tosco P; Lazzarato L
ChemMedChem; 2009 Jun; 4(6):939-45. PubMed ID: 19301318
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a new class of selective cyclooxygenase-2 (COX-2) inhibitor that covalently modifies the isozyme.
Kalgutkar AS; Crews BC; Rowlinson SW; Garner C; Marnett LJ
Adv Exp Med Biol; 1999; 469():139-43. PubMed ID: 10667322
[No Abstract] [Full Text] [Related]
9. Structural approach for COX-2 inhibition.
Michaux C; Charlier C
Mini Rev Med Chem; 2004 Aug; 4(6):603-15. PubMed ID: 15279594
[TBL] [Abstract][Full Text] [Related]
10. 3-(2-Methoxytetrahydrofuran-2-yl)pyrazoles: a novel class of potent, selective cyclooxygenase-2 (COX-2) inhibitors.
Ranatunge RR; Earl RA; Garvey DS; Janero DR; Letts LG; Martino AM; Murty MG; Richardson SK; Schwalb DJ; Young DV; Zemtseva IS
Bioorg Med Chem Lett; 2004 Dec; 14(24):6049-52. PubMed ID: 15546727
[TBL] [Abstract][Full Text] [Related]
11. New pyrazole derivatives: Synthesis, anti-inflammatory activity, cycloxygenase inhibition assay and evaluation of mPGES.
Hassan GS; Abdel Rahman DE; Abdelmajeed EA; Refaey RH; Alaraby Salem M; Nissan YM
Eur J Med Chem; 2019 Jun; 171():332-342. PubMed ID: 30928706
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action in a 4,5-diarylpyrrole series of selective cyclo-oxygenase-2 inhibitors.
Zoete V; Maglia F; Rougée M; Bensasson RV
Free Radic Biol Med; 2000 Jun; 28(11):1638-41. PubMed ID: 10938460
[TBL] [Abstract][Full Text] [Related]
13. Chemometric rationalization of the structural and physicochemical basis for selective cyclooxygenase-2 inhibition: toward more specific ligands.
Filipponi E; Cecchetti V; Tabarrini O; Bonelli D; Fravolini A
J Comput Aided Mol Des; 2000 Mar; 14(3):277-91. PubMed ID: 10756482
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of 6-substituted-3-(4-methanesulfonylphenyl)-4-phenylpyran-2-ones: a novel class of diarylheterocyclic selective cyclooxygenase-2 inhibitors.
Praveen Rao PN; Amini M; Li H; Habeeb AG; Knaus EE
J Med Chem; 2003 Nov; 46(23):4872-82. PubMed ID: 14584938
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence quenching analysis of the association and dissociation of a diarylheterocycle to cyclooxygenase-1 and cyclooxygenase-2: dynamic basis of cyclooxygenase-2 selectivity.
Lanzo CA; Sutin J; Rowlinson S; Talley J; Marnett LJ
Biochemistry; 2000 May; 39(20):6228-34. PubMed ID: 10821698
[TBL] [Abstract][Full Text] [Related]
16. 4-substituted 1,5-diarylpyrazole, analogues of celecoxib: synthesis and preliminary evaluation of biological properties.
Menozzi G; Merello L; Fossa P; Mosti L; Piana A; Mattioli F
Farmaco; 2003 Sep; 58(9):795-808. PubMed ID: 13679172
[TBL] [Abstract][Full Text] [Related]
17. Cox-2-selective inhibitors: the new super aspirins.
DeWitt DL
Mol Pharmacol; 1999 Apr; 55(4):625-31. PubMed ID: 10101019
[No Abstract] [Full Text] [Related]
18. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
19. The Molecular Basis for Dual Fatty Acid Amide Hydrolase (FAAH)/Cyclooxygenase (COX) Inhibition.
Palermo G; Favia AD; Convertino M; De Vivo M
ChemMedChem; 2016 Jun; 11(12):1252-8. PubMed ID: 26593700
[TBL] [Abstract][Full Text] [Related]
20. Kinetic basis for selective inhibition of cyclo-oxygenases.
Gierse JK; Koboldt CM; Walker MC; Seibert K; Isakson PC
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):607-14. PubMed ID: 10215599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
